Login / Signup

Evaluation of a multimarker panel in chronic heart failure: a 10-year follow-up.

Susanne BauerChristina StrackEkrem ÜcerStefan WallnerUte HubauerAndreas LuchnerLars Siegfried MaierCarsten Jungbauer
Published in: Biomarkers in medicine (2021)
Aim: We assessed the 10-year prognostic role of 11 biomarkers with different pathophysiological backgrounds. Materials & methods/results: Blood samples from 144 patients with heart failure were analyzed. After 10 years of follow-up (median follow-up was 104 months), data regarding all-cause mortality were acquired. Regarding Kaplan-Meier analysis, all markers, except TIMP-1 and GDF-15, were significant predictors for all-cause mortality. We created a multimarker model with nt-proBNP, hs-TnT and IGF-BP7 and found that patients in whom all three markers were elevated had a significantly worse long-time prognosis than patients without elevated markers. Conclusion: In a 10-year follow-up, a combination of three biomarkers (NT-proBNP, hs-TnT, IGF-BP7) identified patients with a high risk of mortality.
Keyphrases
  • ejection fraction
  • end stage renal disease
  • newly diagnosed
  • prognostic factors
  • type diabetes
  • cardiovascular disease
  • cardiovascular events
  • electronic health record
  • pi k akt
  • artificial intelligence